Left Renal Artery Murmur (Bruit)
A left renal artery bruit indicates possible renal artery stenosis (RAS) and warrants further evaluation with imaging, but the presence of a bruit alone—even with a diastolic component—is not sufficient to diagnose renovascular hypertension or predict treatment response.
Clinical Significance
An abdominal bruit is one of several clinical features associated with increased likelihood of renovascular hypertension 1. However, the diagnostic value is limited:
- Systolic bruits are heard in 4-20% of young adults without any vascular abnormalities 2
- Diastolic bruits are more specific for hemodynamically significant stenosis, particularly in fibromuscular dysplasia 3
- A bruit is most clinically relevant when blood pressure remains uncontrolled despite adequate medical therapy, especially if the bruit extends into diastole 2
Key Clinical Context
Look for these additional features that increase suspicion for renovascular hypertension 1:
- Refractory hypertension despite multiple medications
- Malignant or accelerated hypertension
- New-onset hypertension after age 50 or severe hypertension (diastolic >110 mmHg) before age 35
- Sudden worsening of previously controlled hypertension
- Deterioration of renal function after starting ACE inhibitors or ARBs
- Generalized atherosclerotic disease elsewhere
Diagnostic Evaluation
For Patients with Normal Renal Function
Duplex Doppler ultrasound is the preferred initial screening test 1:
- Peak systolic velocity (PSV) ≥200 cm/s (sensitivity 91%, specificity 75-96%)
- Renal artery to aortic ratio (RAR) ≥3.5
- Parvus-tardus waveform in distal intrarenal arteries (acceleration time >70 ms)
Alternative imaging modalities 1:
- CT angiography (CTA) or MR angiography (MRA) are more reliable when ultrasound expertise is limited or body habitus/bowel gas obscures visualization
- Both can assess for accessory renal arteries, aortic disease, and other causes of secondary hypertension
Important Caveats
- Ultrasound is operator-dependent and time-consuming
- Significant stenosis is defined as ≥60-70% narrowing (not just any visible narrowing)
- Bilateral disease complicates interpretation of functional significance
Management
Atherosclerotic RAS (90% of cases)
Medical therapy is the recommended first-line treatment 4:
- Optimal antihypertensive regimen including a RAS blocker (ACE inhibitor or ARB)
- High-intensity statin for LDL reduction
- Antiplatelet therapy
- Smoking cessation
- Glycemic control if diabetic
No randomized trial has demonstrated benefit of revascularization (angioplasty/stenting) over medical therapy alone for atherosclerotic RAS 4. The CORAL trial definitively showed no advantage to intervention.
Fibromuscular Dysplasia (10% of cases)
Percutaneous transluminal angioplasty (without stenting) should be performed 4:
- Can normalize blood pressure, especially with recent-onset or resistant hypertension
- Occurs predominantly in women (mean age 53 years)
- Diastolic bruit in fibromuscular dysplasia predicts favorable outcome 3
Consider Revascularization Only When 4:
- Medical management has failed (truly refractory hypertension)
- Progressive worsening of renal function despite optimal medical therapy
- Intractable heart failure (flash pulmonary edema)
- Nonatherosclerotic disease (fibromuscular dysplasia, Takayasu arteritis)
Critical Pitfalls
- Do not assume a bruit equals renovascular hypertension requiring intervention—most patients with atherosclerotic RAS benefit more from medical therapy than revascularization
- Do not use resistive index (RI) >0.80 as absolute contraindication to revascularization—evidence is conflicting 1
- Do not rely on bruit alone—the stenotic artery causing hypertension may be silent while an incidental stenosis produces the audible bruit 5
- Do not order imaging without clinical context—prevalence of incidental RAS increases with age and doesn't always cause hypertension